DWA
ELV icon

Dorsey Wright & Associates’s Elevance Health ELV Stock Holding History

Dorsey Wright & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,367
Closed -$1.73M – 313
2022
Q4 		$1.73M Buy
+3,367
New +$1.71M 0.5% 94
2022
Q2 		$1.72M Buy
+3,571
New +$1.77M 0.5% 88
2017
Q4 		– Sell
-8,884
Closed -$1.69M – 140
2017
Q3 		$1.69M Buy
+8,884
New +$1.69M 0.39% 92

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dorsey Wright & Associates's ELV Position: Q1 2023 in Review

Dorsey Wright & Associates sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 3,367 shares — an estimated $1.73M sold.

Dorsey Wright & Associates first reported a position in ELV in Q3 2017 and held it in 3 quarters. The position peaked at $1.73M in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Dorsey Wright & Associates reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,367 Elevance Health shares in Q1 2023, an estimated $1.73M.
  • Dorsey Wright & Associates first reported a position in Elevance Health in Q3 2017 and held it in 3 quarters.
  • Dorsey Wright & Associates's Elevance Health position peaked at $1.73M in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Dorsey Wright & Associates's 13F filing for Q1 2023, filed 20 Apr 2023.